- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05728073
Does Subtotal Cholecystectomy Rate for Acute Cholecystitis Change With a Previous ERCP?
Study Overview
Status
Intervention / Treatment
Detailed Description
The results of patients who underwent surgery for acute cholecystitis in a single center between January 2016 and December 2019 were included and evaluated retrospectively.
Primary outcome was subtotal cholecystectomy rate. Secondary outcomes were conversion to open, complications and serious complications. Within examining demographic findings, operative records (rates for subtotal cholecystectomy and conversion to open, operative duration) and follow-up results (postoperative complications, serious complications, length of hospital stay and mortality) for all cases were investigated. Complications that Clavien-Dindo Score ≥ 3 accepted as serious complication. Intraoperative detection of gallbladder perforation was also noted and included in comparison. Any biliary tract complication that needed any percutaneous or endoscopic intervention to handle was named as "biliary leak" in the study.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Bakırkoy Dr.Sadi Konuk Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients operated with the diagnosis of acute cholecystitis with an age greater or equal to 18 years old in a single center between January 2016 and December 2019
Exclusion Criteria:
- Initial and direct preferance of open method
- Being diagnosed with malignity after histopathological evaluation
- Being operated just before one week after ERCP or after more than six weeks after ERCP
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Standard (non-ERCP) Group
Patients who underwent surgery for acute cholecystitis without a previous ERCP history.
|
Patients separated to two groups according to having a ERCP history before the operation
|
|
ERCP group
Patients who underwent surgery for acute cholecystitis with a previous ERCP history.
|
Patients separated to two groups according to having a ERCP history before the operation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subtotal Cholecystectomy Rate
Time Frame: Intraoperative
|
Rate of patients needed subtotal cholecystectomy after initial intent of starting laparoscopic to the cholecystectomy
|
Intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Conversion to open
Time Frame: Intraoperative
|
Rate of patients needed conversion to open after initial intent of starting laparoscopic to the cholecystectomy
|
Intraoperative
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complications
Time Frame: Postoperative first 90 days
|
Any complications experienced by patients who underwent emergency operation with the diagnosis of acute cholecystitis
|
Postoperative first 90 days
|
|
Duration of operation
Time Frame: Intraoperative
|
Duration of emergency with the diagnosis of acute cholecystitis
|
Intraoperative
|
|
Length of hospital stay
Time Frame: Postoperative first 90 days
|
Number of days patient stayed with and after the emergency operation with the diagnosis of acute cholecystitis
|
Postoperative first 90 days
|
|
Mortality
Time Frame: Postoperative first 90 days
|
Number of patients that died after the emergency operation with the diagnosis of acute cholecystitis
|
Postoperative first 90 days
|
|
Serious complications
Time Frame: Postoperative first 90 days
|
Any complications that has a Clavien-Dindo Score ≥ 3 experienced by patients who underwent emergency operation with the diagnosis of acute cholecystitis.
(Clavien Dindo Score System that classifying post-operative complications in 5 main levels.
Higher the score, the more significant complications.
While level 1 is the lightest, level 5 means death)
|
Postoperative first 90 days
|
Collaborators and Investigators
Investigators
- Study Chair: Mehmet Karabulut, University of Health Sciences, Bakirkoy Dr.Sadi Konuk Training and Research Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20230205
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cholecystectomy, Laparoscopic
-
Wake Forest University Health SciencesAmerican College of SurgeonsCompletedCholecystectomy, Laparoscopic | Appendectomy, Laparoscopic | Cholecystectomy, RoboticUnited States
-
Clinical Research Centre, MalaysiaCompletedComplication Laparoscopic Cholecystectomy | Conversion Laparoscopic to Open CholecystectomyMalaysia
-
Intuitive SurgicalCompletedLaparoscopic Cholecystectomy | Robotic-assisted CholecystectomyUnited States
-
Assiut UniversityNot yet recruiting
-
IHU StrasbourgScialytics SASRecruitingCholecystectomy, LaparoscopicFrance
-
Assiut UniversityNot yet recruiting
-
Mohamed Bakr Mohamed AhmedNot yet recruitingLaparoscopic Cholecystectomy
-
Istanbul University - CerrahpasaActive, not recruitingCholecystectomy, LaparoscopicTurkey (Türkiye)
-
Ulas AdayCompletedLaparoscopic CholecystectomyTurkey (Türkiye)
-
Mansoura UniversityCompletedLaparoscopic CholecystectomyEgypt
Clinical Trials on ERCP
-
First People's Hospital of HangzhouCompletedCholedocholithiasis | Common Bile Duct CalculiChina
-
McGill University Health Centre/Research Institute...Unity Health Toronto; Jewish General HospitalRecruitingCancer GiCanada, France, India
-
Minia UniversityCompletedGallstones Complicated by CBD StonesEgypt
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Active, not recruitingERCP | Common Bile Duct Stone | Robot SurgeryChina
-
Beijing Friendship HospitalCompletedCholedocholithiasis With Acute CholangitisChina
-
Weill Medical College of Cornell UniversityUnknownPancreatic Cancer | Cholangiocarcinoma | Bile Duct Cancer | Chronic Pancreatitis | Biliary Stricture | Biliary Obstruction | Ampullary Cancer | Stent Obstruction | Proximal Duct Stricture | Distal Duct Stricture | Biliary Sphincter Stenosis | Impacted Stones | Peri-ampullary Diverticula | Altered AnatomyUnited States, Brazil
-
Beijing Friendship HospitalCompletedCholedocholithiasis With Acute CholangitisChina
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedSphincter of Oddi DysfunctionUnited States
-
Mansoura UniversityCompleted
-
Yonsei UniversityNot yet recruitingResectable Pancreatic Cancer With Biliary ObstructionKorea, Republic of